Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,100.00
Bid: 4,070.00
Ask: 4,140.00
Change: 60.00 (1.49%)
Spread: 70.00 (1.72%)
Open: 4,020.00
High: 4,120.00
Low: 4,020.00
Prev. Close: 4,040.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
9th Nov 201011:51 amRNSNet Asset Value(s)
8th Nov 201011:31 amRNSChange of Adviser and Broker (Correction)
12th Oct 201010:38 amRNSDoc re. Half-Yearly Report
12th Oct 20109:40 amRNSNet Asset Value(s)
28th Sep 20101:16 pmRNSHalf Yearly Report
13th Sep 20105:52 pmRNSTransaction in Own Shares
13th Sep 20105:21 pmRNSTransaction in a close period
10th Sep 20103:37 pmRNSDirector/PDMR Shareholding
9th Sep 20104:55 pmRNSNet Asset Value(s)
11th Aug 20101:16 pmRNSNet Asset Value(s)
9th Aug 201012:04 pmRNSHolding(s) in Company
15th Jul 20105:55 pmRNSDirector/PDMR Shareholding
9th Jul 20105:09 pmRNSAdditional Listing
9th Jul 201012:48 pmRNSNet Asset Value(s)
8th Jul 201011:50 amRNSHolding(s) in Company
6th Jul 20104:16 pmRNSTransaction in Own Shares
29th Jun 20106:06 pmRNSResult of AGM
22nd Jun 20104:16 pmRNSInterim Management Statement
21st Jun 20106:13 pmRNSAnnual Information Update
21st Jun 20106:09 pmRNSDoc re. (Annual Financial Report)
18th Jun 201010:22 amRNSHolding(s) in Company
18th Jun 201010:22 amRNSHolding(s) in Company
7th Jun 201010:35 amRNSNet Asset Value(s)
4th Jun 20103:44 pmRNSTransaction in Own Shares
2nd Jun 20105:18 pmRNSPortfolio Update
25th May 20106:32 pmRNSFinal Results
13th May 201010:19 amRNSNet Asset Value(s)
12th Apr 20104:01 pmRNSNet Asset Value(s)
9th Apr 20101:07 pmRNSExercise of Options
6th Apr 20104:14 pmRNSDirector/PDMR Shareholding
24th Mar 201010:16 amRNSDirector/PDMR Shareholding
16th Mar 20105:04 pmRNSDirector/PDMR Shareholding
15th Mar 20104:38 pmRNSTransactions in a closed period
12th Mar 20105:31 pmRNSNet Asset Value(s)
16th Feb 20101:41 pmRNSPortfolio Update
10th Feb 20109:49 amRNSNet Asset Value(s)
12th Jan 201010:33 amRNSNet Asset Value(s)
4th Jan 201011:14 amRNSHolding(s) in Company
10th Dec 20099:53 amRNSInterim Management Statement
8th Dec 200910:23 amRNSNet Asset Value(s)
3rd Dec 200912:44 pmRNSHolding(s) in Company
16th Nov 20099:41 amRNSNet Asset Value(s)
4th Nov 200912:14 pmRNSHolding(s) in Company
12th Oct 20092:31 pmRNSNet Asset Value(s)
7th Oct 200910:07 amRNSHolding(s) in Company
30th Sep 200911:57 amRNSHolding(s) in Company
30th Sep 200910:42 amRNSDoc re. Half Yearly Report
29th Sep 20099:30 amRNSTransaction in Own Shares
28th Sep 200911:04 amRNSHolding(s) in Company
24th Sep 200911:04 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.